Vedolizumab-Induced Liver Injury

Abstract: Drug-induced liver injury is an important cause of acute liver injury. Immunomodulatory therapies, such as vedolizumab (VDZ), are being increasingly used for the treatment of several diseases, most importantly inflammatory bowel disease. Several studies have demonstrated the safety of this...

ver descrição completa

Detalhes bibliográficos
Autor principal: Saraiva,Miguel Mascarenhas (author)
Outros Autores: Ribeiro,Tiago (author), Dias,Emanuel (author), Lopes,Joanne Lopes (author), Cardoso,Hélder (author), Macedo,Guilherme (author)
Formato: report
Idioma:eng
Publicado em: 2021
Assuntos:
Vedolizumab
Acute liver injury
Hepatotoxicity
Drug-induced liver injury
Inflammatory bowel disease
Texto completo:http://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452021000600410
País:Portugal
Oai:oai:scielo:S2341-45452021000600410

Texto Completo

http://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452021000600410

Registros relacionados